Control of inflammation by stromal Hedgehog pathway activation restrains colitis

Area of Science:

• Immunology
• Gastroenterology
• Molecular Biology

Background:

• Inflammation disrupts tissue integrity and function, contributing to various diseases.
• Signals regulating inflammation are critical therapeutic targets.
• The Hedgehog signaling pathway's role in colon inflammation is not fully understood.

Purpose of the Study:

• To investigate the role of the Hedgehog signaling pathway in mouse models of colon inflammation (colitis).
• To explore the therapeutic potential of modulating the Hedgehog pathway in colitis and associated adenocarcinoma.

Main Methods:

• Utilized genetic manipulation and pharmacologic agents to inhibit or activate the Hedgehog pathway in mice.
• Assessed the impact of Hedgehog pathway modulation on colitis severity and adenocarcinoma development.
• Investigated the cellular source and mechanism of Hedgehog pathway action within the colon, including cytokine expression and immune cell populations.

Main Results:

• Hedgehog pathway inhibition exacerbated colitis, while activation ameliorated it and suppressed colitis-induced adenocarcinoma.
• Hedgehog signaling in the colon acts on stromal cells, not directly on epithelium, to induce Interleukin-10 (IL-10) production.
• IL-10 is essential for the protective effects of Hedgehog pathway activation, which also increases regulatory T cells (CD4+Foxp3+).

Conclusions:

• The Hedgehog pathway, acting via stromal cells and IL-10, plays a crucial protective role in colon inflammation.
• Pharmacologic augmentation of Hedgehog pathway activity and stromal IL-10 represents a promising therapeutic strategy for colitis.
• Stromal cells are identified as key regulators of colon inflammation, suggesting their manipulation as a treatment approach.